凱中精密(002823.SZ):擬投資建設惠州生產基地一期項目
格隆匯3月2日丨凱中精密(002823.SZ)公佈,公司於2022年3月2日召開第四屆董事會第八次會議,審議通過了《關於投資建設惠州生產基地一期項目的議案》,公司擬以自有及自籌通資金人民幣5億元通過全資子公司惠州市凱中精密技術有限公司(“惠州凱中”)投資建設惠州生產基地一期項目。
建設內容:生產廠房及配套建/構築物約6萬平方米,新能源汽車零組件等產品生產線100條。
惠州生產基地一期項目毗鄰公司深圳總部和研發中心,項目建成投產後將為新能源汽車零組件等業務提供有力的產能保障,更好地滿足公司客户持續增長的需求,有助於增強公司市場競爭力、提升市場份額。同時,惠州生產基地與總部互補協同,有助於降低生產成本、提升盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.